✨ Medicine Distribution Consents
4510 NEW ZEALAND GAZETTE, No. 188 17 DECEMBER 2009
Schedule
Product:
Priligy
Active Ingredient:
Dapoxetine hydrochloride 33.6mg equivalent to 30mg dapoxetine
Dosage Form:
Film coated tablet
New Zealand Sponsor:
Janssen-Cilag (New Zealand) Limited
Manufacturer:
Janssen Ortho LLC, Mamey Ward, Gurabo, Puerto Rico
Dated this 11th day of December 2009.
ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go10401
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which is referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:
Schedule
Product:
Oratane
Active Ingredient:
Isotretinoin 40mg
Dosage Form:
Soft gelatin capsule
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturers:
Swiss Caps AG, Kirchberg, Switzerland
Ayanda GmbH & Co. KG, Pritzwalk, Germany
Product:
Oratane
Active Ingredient:
Isotretinoin 20mg
Dosage Form:
Soft gelatin capsule
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturers:
Swiss Caps AG, Kirchberg, Switzerland
Ayanda GmbH & Co. KG, Pritzwalk, Germany
Product:
Oratane
Active Ingredient:
Isotretinoin 10mg
Dosage Form:
Soft gelatin capsule
New Zealand Sponsor:
Douglas Pharmaceuticals Limited
Manufacturers:
Swiss Caps AG, Kirchberg, Switzerland
Ayanda GmbH & Co. KG, Pritzwalk, Germany
Dated this 11th day of December 2009.
ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go10400
Consent to the Distribution of New Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product:
Arrow - Carvedilol
Active Ingredient:
Carvedilol 3.125mg
Dosage Form:
Tablet
New Zealand Sponsor:
Arrow Pharmaceuticals (NZ) Limited
Manufacturer:
Elpen SA, Pikermi Attica, Greece
Product:
Arrow - Carvedilol
Active Ingredient:
Carvedilol 6.25mg
Dosage Form:
Tablet
New Zealand Sponsor:
Arrow Pharmaceuticals (NZ) Limited
Manufacturer:
Elpen SA, Pikermi Attica, Greece
Product:
Arrow - Carvedilol
Active Ingredient:
Carvedilol 12.5mg
Dosage Form:
Tablet
New Zealand Sponsor:
Arrow Pharmaceuticals (NZ) Limited
Manufacturer:
Elpen SA, Pikermi Attica, Greece
Next Page →
✨ LLM interpretation of page content
🏥
Corrigendum—Consent to the Distribution of a New Medicine
(continued from previous page)
🏥 Health & Social Welfare11 December 2009
Medicines Act, New medicine, Provisional Consent, Priligy
- ANTHONY HILL, Deputy Director-General, Sector Accountability and Funding Directorate, Ministry of Health
🏥 Consent to the Distribution of a New Medicine
🏥 Health & Social Welfare11 December 2009
Medicines Act, New medicine, Provisional Consent, Oratane, Isotretinoin
- ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
🏥 Consent to the Distribution of New Medicines
🏥 Health & Social Welfare11 December 2009
Medicines Act, New medicines, Provisional Consent, Arrow - Carvedilol, Carvedilol
- ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health
NZ Gazette 2009, No 188